Product
Belatacep
1 clinical trial
1 indication
Indication
Kidney Transplant RejectionClinical trial
Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)Status: Not yet recruiting, Estimated PCD: 2031-03-01